These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16209647)

  • 1. Multiplex proteomic approaches to sepsis research: case studies employing new technologies.
    Heuer JG; Cummins DJ; Edmonds BT
    Expert Rev Proteomics; 2005 Oct; 2(5):669-80. PubMed ID: 16209647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic resources: integrating biomedical information in humans.
    Suresh S; Sujatha Mohan S; Mishra G; Hanumanthu GR; Suresh M; Reddy R; Pandey A
    Gene; 2005 Dec; 364():13-8. PubMed ID: 16202541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics makes progress in cartilage and arthritis research.
    Wilson R; Whitelock JM; Bateman JF
    Matrix Biol; 2009 Apr; 28(3):121-8. PubMed ID: 19379666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteomic analysis of cancer cells].
    Tomancová A; Sedo O; Zdráhal Z; Mayer J; Pospísilová S
    Klin Onkol; 2009; 22(5):210-7. PubMed ID: 19886358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HepatoProteomics: applying proteomic technologies to the study of liver function and disease.
    Diamond DL; Proll SC; Jacobs JM; Chan EY; Camp DG; Smith RD; Katze MG
    Hepatology; 2006 Aug; 44(2):299-308. PubMed ID: 16871559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
    Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
    Qoronfleh MW
    Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics: recent applications and new technologies.
    Elrick MM; Walgren JL; Mitchell MD; Thompson DC
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray profiling of antiviral antibodies for the development of diagnostics, vaccines, and therapeutics.
    Neuman de Vegvar HE; Robinson WH
    Clin Immunol; 2004 May; 111(2):196-201. PubMed ID: 15137952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic approach to aging research.
    Sharov VS; Schöneich C
    Expert Rev Proteomics; 2007 Apr; 4(2):309-21. PubMed ID: 17425465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future approaches of nanomedicine in clinical science.
    Brewer M; Zhang T; Dong W; Rutherford M; Tian ZR
    Med Clin North Am; 2007 Sep; 91(5):963-1016. PubMed ID: 17826113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational research in the development of novel sepsis therapeutics: logical deductive reasoning or mission impossible?
    Opal SM; Patrozou E
    Crit Care Med; 2009 Jan; 37(1 Suppl):S10-5. PubMed ID: 19104207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular proteomic analysis.
    Suzuki T; Nagai R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):28-34. PubMed ID: 17350900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technologies to shape the future: proteomics applications in anesthesiology and critical care medicine.
    Atkins JH; Johansson JS
    Anesth Analg; 2006 Apr; 102(4):1207-16. PubMed ID: 16551925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.